Related Experiment Video
Updated: Oct 3, 2025

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
Adverse Outcome Pathways as Versatile Tools in Liver Toxicity Testing
Emma Arnesdotter1, Eva Gijbels1, Bruna Dos Santos Rodrigues1
1Department of Pharmaceutical and Pharmacological Sciences, Entity of In Vitro Toxicology, Vrije Universiteit Brussel, Brussels, Belgium.
Abstract:
Adverse outcome pathways (AOPs) are tools to capture and visualize mechanisms driving toxicological effects. They share a common structure consisting of a molecular initiating event, a series of key events connected by key event relationships and an adverse outcome. Development and evaluation of AOPs ideally comply with guidelines issued by the Organization for Economic Cooperation and Development. AOPs have been introduced for major types of hepatotoxicity, which is not a surprise, as the liver is a frequent target for systemic adversity. Various applications for AOPs have been proposed in the areas of toxicology and chemical risk assessment, in particular in relation to the establishment of quantitative structure-activity relationships, the elaboration of prioritization strategies, and the development of novel in vitro toxicity screening tests and testing strategies.
Insights
Adverse outcome pathways (AOPs) visualize toxicological mechanisms. These pathways aid in chemical risk assessment, prioritizing substances, and developing new in vitro toxicity tests.
Area of Science:
- Toxicology
- Chemical Risk Assessment
Background:
- Adverse outcome pathways (AOPs) provide a framework to understand and visualize the mechanistic basis of toxicological effects.
- AOPs consist of a molecular initiating event, key events, key event relationships, and an adverse outcome.
- Development and evaluation of AOPs should align with Organization for Economic Cooperation and Development guidelines.
Purpose of the Study:
- To highlight the utility and applications of Adverse Outcome Pathways (AOPs) in toxicology and chemical risk assessment.
- To emphasize the role of AOPs in understanding hepatotoxicity.
- To explore the application of AOPs in quantitative structure-activity relationships, prioritization, and in vitro testing.
Main Methods:
- Conceptual framework development for Adverse Outcome Pathways.
- Review of existing AOPs, particularly those related to hepatotoxicity.
- Analysis of proposed applications in risk assessment and testing strategies.
Main Results:
- AOPs offer a structured approach to toxicological mechanisms.
- The liver is a common target for systemic toxicity, leading to AOP development for hepatotoxicity.
- AOPs facilitate quantitative structure-activity relationships, prioritization, and novel in vitro toxicity testing.
Conclusions:
- Adverse outcome pathways are valuable tools for understanding and predicting toxicological effects.
- AOPs have significant potential to advance chemical risk assessment and the development of predictive toxicology methods.
- The structured nature of AOPs supports their integration into regulatory science and testing strategies.
More Related Videos
08:25Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
Published on: June 5, 2020
17:28Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
Related Concept Videos
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Mutagenicity and Carcinogenicity